08/04/2025
6:04 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/04/2025
6:09 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2025
8:03 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2025
3:45 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2025
5:41 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
5:42 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
4:44 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
4:45 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2025
8:01 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
5:14 PM | JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
5:18 PM | Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KRYS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. |
06/30/2025
5:23 PM | Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
4:59 PM | Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
5:04 PM | Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
5:09 PM | Krystal Biotech (Issuer)
Mason Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
4:12 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
7:08 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
7:09 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:53 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
3:44 PM | Krystal Biotech (Filer)
| Form ARS | |
04/03/2025
3:38 PM | Krystal Biotech (Filer)
| Form DEF 14A | |
03/13/2025
5:04 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
5:06 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
5:58 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
6:00 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
6:01 PM | Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
10:52 AM | Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
6:19 AM | Krystal Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
6:25 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
6:51 AM | Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
12/18/2024
7:39 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:27 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
5:28 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:22 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2024
7:30 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:00 PM | Krystal Biotech (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/04/2024
7:04 AM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
7:05 AM | Krystal Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2024
11:28 AM | Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
09/13/2024
4:41 PM | Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:44 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
What Are Some Strategies to Help Lower RMD Taxes? (Ad) Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg.
SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest. Click here to see the six strategies and get your free advisor matches today. |
09/13/2024
4:45 PM | Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:33 PM | Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:33 PM | Krishnan Suma (Reporting)
Krystal Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:31 PM | Krystal Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access